Radiation Oncologist Joshua Halpern, MD Joins New York Cancer & Blood Specialists

Feb 1, 2024 | Business

 New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, is pleased to announce the addition of board-certified Radiation Oncologist Dr. Joshua Halpern. Dr. Halpern will practice at 1781 Hylan Blvd, Staten Island, NY 11305.

“We are proud to welcome Dr. Halpern to our team of radiation oncologists,” said Jeff Vacirca, MD, CEO of NYCBS. “His extensive background as a radiation oncologist and experienced brachytherapist, coupled with research expertise in basic and cancer immunology, radiation biology, cell culture, and clinical research in radiation oncology, will bring valuable benefits to the Staten Island community.

With over 40 years of experience, Dr. Halpern developed an interest in oncology after the loss of his father to cancer in his youth. He pursued specialized training in Medical Oncology, followed by comprehensive residencies and fellowships in Radiation Oncology and Brachytherapy (radioactive isotope implantations) at renowned oncology centers across the United States.

Dr. Halpern earned his Doctor of Medicine degree at Hadassah Medical School in Jerusalem, Israel. He completed a residency in the Department of Hematology at Hadassah University in Jerusalem and Roswell Park Cancer Center. He furthered his training, completing residencies in Radiation and Clinical Oncology and Medical Oncology. Dr. Halpern completed a Fellowship in GYN Radiotherapy and Brachytherapy at Roswell Park Memorial Institute and a Senior Fellowship in Radiation Therapy of Breast and Lung Tumors at MD Anderson Cancer Center. He previously practiced at Seagate Radiation Oncology PC, The Brooklyn Hospital Center and other sites in the NYC Metropolitan area.

“Throughout my career, I have dedicated extensive attention to direct patient care and to maintaining the best quality of life for all the patients under my care,” said Dr. Halpern.

Dr. Halpern speaks fluent English and Hebrew. In his free time, he enjoys painting and biking.

To make an appointment with Dr. Halpern, please call 718-351-9750.

For more information, visit nycancer.com.

About New York Cancer & Blood Specialists:
New York Cancer & Blood Specialists (NYCBS) is a leading oncology practice in the New York Metropolitan area committed to providing world-class, patient-centered, affordable care to patients with cancer and blood disorders in their own communities, close to family and friends. NYCBS has more than 30 locations and 35 hospital affiliations throughout Nassau and Suffolk counties, in the Bronx, Manhattan, Queens, Staten Island, Brooklyn and Upstate New York. We offer a multidisciplinary and comprehensive approach to care that utilizes the most advanced imaging, state-of-the-art therapies, cutting-edge clinical trials, on-site pharmacies, and an in-house laboratory with a full range of pathology services. Advocating for and ensuring the health and well-being of our patients is and always will be our top priority. For more information, visit www.nycancer.com.

New York Cancer & Blood Specialists
Sarah Gould, Communications Director
631-574-8360

ContactContact

Categories

  • Business
  • Cancer
  • Medical & Health
  • Personnel Announcements
  • Radiology & Imaging
  • Surgery

Radiation Oncologist Dr. Paul Gliedman Joins New York Cancer & Blood Specialists in Brooklyn

Oct 3, 2023 | Business

 New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, is proud to announce the addition of board-certified Radiation Oncologist Dr. Paul Gliedman, MD. Dr. Gliedman will practice at 2236 Nostrand Avenue, Brooklyn, NY 11210 and 121 DeKalb Avenue, Brooklyn, NY 11201.

“Dr. Gliedman brings an unparalleled level of expertise and leadership that will further elevate our radiation oncology team,” said Jeff Vacirca, MD, CEO of NYCBS. “Delivering the highest quality of patient care is our number one priority, and his addition will be a tremendous asset to NYCBS.”

Dr. Gliedman has decades of experience managing cancers of all sites, specializing in breast, prostate, brain tumors, GI, and gynecologic cancer. He has expertise in Cranial and Body Stereotactic Radiosurgery.

“I believe in the power of listening to my patients, allowing their voices to guide me in understanding their needs, “ said Dr. Gliedman. Through this mutual exchange, I gain invaluable insights, enabling me to craft tailored treatment options that align perfectly with their unique circumstances. My goal is to create a treatment plan that not only addresses their cancer but is also a perfect fit for each individual.”

Dr. Gliedman has held numerous Medical Director positions in hospital and multi-specialty practice settings. He is the Director of Radiation Oncology at Mount Sinai Brooklyn and prior to joining NYCBS was the Medical Director of Radiation Oncology at Vantage Health, Mount Sinai West and Hackensack Medical Center.

Dr. Gliedman received his Doctor of Medicine degree from Columbia University Vagelos College of Physicians and Surgeons. He completed his medical internship at Mount Sinai Beth Israel and his residency in Radiation Oncology at NYU Langone Medical Center.

Dr. Gliedman has frequently been recognized in New York Magazine’s “Best Doctors” list and has been a Castle Connolly’s Top Doctor for over two decades.

To make an appointment at Nostrand Avenue, please call 718-406-9454.
To make an appointment at DeKalb Avenue, please call 718-250-8248.
For more information, visit nycancer.com

About New York Cancer & Blood Specialists:
New York Cancer & Blood Specialists (NYCBS) is a leading oncology practice in the New York Metropolitan area committed to providing world-class, patient-centered affordable care to patients with cancer and blood disorders in their own communities, close to family and friends. NYCBS has more than 30 locations and 35 hospital affiliations throughout Nassau and Suffolk counties, in the Bronx, Manhattan, Queens, Staten Island, and Brooklyn. We offer a multidisciplinary and comprehensive approach to care that utilizes the most advanced imaging, state-of-the-art therapies, cutting-edge clinical trials, on-site pharmacies, and an in-house laboratory with a full range of pathology services. Advocating for and ensuring the health and well-being of our patients is and always will be our top priority. For more information, visit www.nycancer.com.

New York Cancer & Blood Specialists
Sarah Gould, Communications Director
631-574-8360

ContactContact

Categories

  • Business
  • Cancer
  • Medical & Health
  • Personnel Announcements
  • Radiology & Imaging
  • Surgery

Greenpeace radiation investigation at Chornobyl to assess accuracy of IAEA data

Jul 19, 2022 | Business

Chornobyl, Ukraine – WEBWIRE –



Near the ruins of the Chornobyl nuclear power plant, an international team of radiation experts led by Greenpeace Germany is examining abandoned Russian positions for radioactive contamination. Trenches and dugouts were built by Russian soldiers during their occupation of the Chornobyl site in March. About 600 soldiers were deployed there. The research project is being conducted with the approval of the Ukrainian government and in cooperation with scientists from the State Agency of Ukraine on the Exclusion Zone Management (SAUEZM).



For the first time since the beginning of the Russian invasion, independent measurements will be taken and the statement of the International Atomic Energy Agency (IAEA) will be assessed. According to the IAEA, while there was increased radiation the levels did not pose a great danger to the environment or people. The IAEA’s deputy director is Mikhail Chudakov, a long-time employee of the Russian nuclear company Rosatom.[1]


Shaun Burnie, a nuclear expert from Greenpeace Germany, on site in Chornobyl, said: 


“We want to know what really happened on the ground. The IAEA’s information so far is insufficient. The Ukrainian authorities are enabling the Greenpeace Germany research team to gather independent information about radiation safety in the region. This includes investigating the radioactive contamination that deposited in the Exclusion Zone when the Chornobyl reactor exploded in 1986. Between seven and nine tonnes of nuclear fuel were pulverized and ejected into the atmosphere in the 1986 explosion.” 


During the Russian occupation of the Chornobyl region, Greenpeace experts warned that this could lead to increased radioactive contamination. But the IAEA gave an “all-clear”. The nuclear agency has a mandate to promote nuclear power.[2]


“While the European Commission actively supports nuclear power by including it in its taxonomy. It’s more important than ever to investigate the environmental impact of Chornobyl, the world’s worst nuclear disaster,” said Burnie.


Greenpeace Germany will present the results of the Chornobyl radiation research, in English, at a press conference in Kyiv on July 20 at 9:00 am CEST (ZOOM Link: https://t1p.de/dzbks).


Photo and video are available via Box. Video: https://t1p.de/d0zww Photo: https://t1p.de/31enn


Press conference on July 20 at 9:00 am CEST via ZOOM link: https://t1p.de/dzbks


Notes


[1] https://www.greenpeace.org/international/press-release/52713/greenpeace-iaea-ties-russian-state-nuclear-energy/ 


[2] https://www.iaea.org/about/statute